| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 858.10M | 1.67B | 1.03B | -720.40M | 1.50B | 634.43M |
| Gross Profit | 353.00M | 1.67B | 1.03B | -1.29B | 1.49B | 634.43M |
| EBITDA | 13.80M | 49.70M | 31.40M | -48.40M | 42.19M | 52.04M |
| Net Income | -7.90M | 3.90M | 18.70M | -33.70M | 27.29M | 21.19M |
Balance Sheet | ||||||
| Total Assets | 13.51B | 12.76B | 12.13B | 11.14B | 9.42B | 8.86B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 138.00M | 146.00M | 204.60M | 70.09M | 105.35M |
| Total Debt | 203.80M | 206.20M | 209.30M | 213.23M | 49.46M | 71.44M |
| Total Liabilities | 13.22B | 12.44B | 11.77B | 10.81B | 8.96B | 8.37B |
| Stockholders Equity | 293.30M | 314.40M | 359.90M | 333.12M | 458.17M | 487.07M |
Cash Flow | ||||||
| Free Cash Flow | 44.70M | 37.80M | -35.70M | -80.43M | 20.69M | 49.34M |
| Operating Cash Flow | 45.90M | 38.60M | -34.90M | -76.92M | 24.32M | 50.20M |
| Investing Cash Flow | 4.60M | 5.00M | 29.50M | 52.05M | -3.64M | 1.88M |
| Financing Cash Flow | -33.90M | -49.70M | -49.80M | 121.30M | -52.25M | -61.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £705.49M | -67.29 | -2.53% | 8.03% | -48.03% | -289.17% | |
71 Outperform | £30.41B | 11.99 | 20.51% | 1.56% | 37.94% | 291.37% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £7.41B | -11.66 | -49.24% | 7.48% | -34.62% | -19.20% | |
67 Neutral | £385.41M | -84.82 | -20.10% | ― | 29.58% | 17.32% | |
65 Neutral | £740.80M | -19.45 | -76.14% | ― | -35.05% | 74.73% | |
58 Neutral | £69.71M | 38.41 | 9.65% | 9.33% | -52.34% | -65.35% |
Chesnara has confirmed that its issued share capital stands at 230,930,471 ordinary shares of 5p each, with no shares held in treasury, meaning the total number of voting rights in the company is 230,930,471. The disclosure, made in line with the UK Financial Conduct Authority’s transparency rules, provides shareholders and potential investors with the reference figure needed to determine whether they must report holdings or changes in their interests in Chesnara, reinforcing transparency around the company’s ownership structure.
The most recent analyst rating on (GB:CSN) stock is a Hold with a £321.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc has confirmed that its issued share capital comprises 230,899,448 ordinary shares of 5 pence each, with no shares held in treasury, giving a total of 230,899,448 voting rights. The disclosure, made in line with UK transparency rules, provides investors with the reference figure needed to assess and report any holdings or changes in their interest in the company, reinforcing regulatory compliance and transparency for shareholders.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £335.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc has received UK regulatory approval for its proposed acquisition of HSBC Life (UK) Limited for £260 million, with plans to complete the transaction by the end of January 2026. This acquisition aligns with Chesnara’s strategy of expanding through value-adding acquisitions, potentially enhancing its market position and offering new growth opportunities in the life and pensions sector.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc has announced a change in its registered office location to Winckley Square, Preston, effective December 11, 2025. This change is in compliance with UK Market Abuse Regulation and FCA’s Disclosure and Transparency Rules, indicating a strategic move to enhance operational efficiency and stakeholder transparency.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC has announced its total voting rights, with its issued share capital comprising 230,803,427 ordinary shares, each carrying one voting right. This announcement is in line with the company’s compliance with the FCA’s Disclosure Guidance and Transparency Rules, providing shareholders the necessary information to assess their interests in the company.
The most recent analyst rating on (GB:CSN) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.